Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02390167 · ClinicalTrials.gov registry record · NA
Evaluation of a Ascensia ONYX NEXT Investigational Blood Glucose Monitoring System
A NA study of Diabetes, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 376
- Enrollment target
- 2
- Study locations
NCT02390167: Completed NA study of Diabetes, sponsored by Ascensia Diabetes Care.
NCT02390167 is a NA study of Diabetes that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 376 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02390167, a NA study of Diabetes, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 376 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study was to determine if untrained subjects with diabetes and without diabetes could operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid glucose results.
Primary Outcome
Untrained subjects WITH Diabetes (332) self-tested fingerstick blood using an Investigational Blood Glucose Monitoring System (BGMS). BGMS results were compared with subject capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI Analyzer BG results were used to calculate the percent of BGMS results within +/- 15 mg/dL (\<100 mg/dL YSI capillary plasma) and +/- 15% (\>=100 mg/dL YSI capillary plasma).
Conditions Studied
Interventions
- DEVICE ONYX NEXT BGMS
Study Locations (2)
California
- AMCR Institute - Escondido
- Diablo Clinical Research - Walnut Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT02390167 record still lists
NCT02390167 is an interventional study that assigns participants to a tested intervention. The registered 376 participants enrollment target is mid-sized for trials with a published cap, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which ONYX NEXT BGMS is the first listed.
NCT02390167 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02390167 about?
NCT02390167 is a clinical study titled "Evaluation of a Ascensia ONYX NEXT Investigational Blood Glucose Monitoring System". The purpose of this study was to determine if untrained subjects with diabetes and without diabetes could operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid glucose results.
What is the current status of trial NCT02390167?
This trial is currently completed. It is a NA study. The enrollment target is 376 participants. The study started on 2015-03. Estimated completion is 2015-04.
What conditions does trial NCT02390167 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT02390167?
The interventions under investigation include: ONYX NEXT BGMS (DEVICE).
Who is sponsoring clinical trial NCT02390167?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02390167 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02390167's enrollment target sits among peer trials
376 93rd of 338 higher than 245 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03102125 · 376 participants · Phase 4
Allograft Dysfunction in Heart Transplant
- NCT05055297 · 376 participants · NA
SELUTION4BTK Trial
- NCT05963971 · 376 participants · NA
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
- NCT06696352 · 376 participants · NA
Partners4Pain & Wellbeing: A Randomized Trial of Community Supported Complementary and Integrative Health Self-management for Back Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia